Research Methodology and Health Technology Assessment
|Course code PHAR3204||Units 10||Level 3000||Faculty of Health and MedicineSchool of Biomedical Sciences and Pharmacy|
Provides students with an understanding of the methods used to measure consumption, beneficial and adverse effects, and cost-effectiveness of drugs in communities; research design and skills used to appraise epidemiological research and clinical trial design.
The course includes biostatistics to a level that enables the student to apply statistical reasoning to epidemiological studies and research. Students will also obtain skills in the development and design of research protocol and methodology as it relates to epidemiological and health research.
This course is a Compulsory Program Component that students must pass in order to progress in the Bachelor of Pharmacy (Honours).
Not available in 2015
|Objectives||At the end of this course students will be able to:|
1. Understand the techniques used to measure medicinal drug consumption;
2. Understand the factors that influence the prescribing and consumption of medicinal drugs;
3. Understand the methods used to measure beneficial and adverse effects of drugs in the community;
4. Be able to correctly interpret data on drug consumption and effects;
5. Understand the techniques used in measuring the cost-effectiveness of drugs;
6. Be able to correctly interpret pharmacoeconomic data and understand how cost-effectiveness data can be used to set drug prices and control drug budgets;
7. Understand the basic principles of biostatistics to be able to apply statistical reasoning to pharmacy related research;
8. Understand the underlying principles of the design and development of research protocol methodology as it relates to pharmacy related studies.
|Content||1. Drug utilisation studies, international measures of drug consumption.|
2. International comparisons of drug consumption, the impact of socio-economic factors and pharmaceutical industry actions on prescribing and consumption of medicinal drugs.
3. Measuring efficacy of drugs by randomised and non-randomised studies, biostatistical measures of drug use and effects.
4. Logic of cohort and case-control studies of adverse effects, voluntary adverse reaction reports and their interpretation, measuring the costs and outcomes of community drug use.
5. Cost-minimisation, cost-effectiveness and cost-utility analysis, evidence-based medicine and pharmacoeconomic analysis, using pharmacoeconomic analyses to make formulary decisions and set prices.
6. Reference pricing, evidence-based procurement techniques in drug program management.
8. Research skills.
|Assumed Knowledge||MATH1110 Mathematics 1|
|Modes of Delivery||Internal Mode|
Self Directed Learning
|Contact Hours||Lecture: for 3 hour(s) per Week for 10 weeks|
Tutorial: for 2 hour(s) per Week for 10 weeks